- Lilly (Boston, MA)
- …for people who are determined to make life better for people around the world. ** Gene Editing Off- Target Safety Lead; Lilly Genetic Therapies** Eli ... off- target biology, NGS technologies, and laboratory automation to support the gene editing off- target safety strategy. + Develop and execute… more
- Editas Medicine (Cambridge, MA)
- …with regulatory agencies (eg, FDA, EMA) on topics related to gene editing safety and off- target analysis is strongly preferred. Benefits Editas ... problem solvers, harnessing the power and potential of CRISPR gene editing to transform the future of...(NGS) datasets to identify and characterize potential on- and off- target editing events. * Drive the evaluation… more
- Lilly (Boston, MA)
- …cardiovascular disease, potentially transforming treatment from chronic management to single-course gene editing medicines. The company's initial three programs ... by world-leading experts in cardiovascular medicine, human genetics and gene - editing , Verve is pioneering a new approach...- VERVE-101, VERVE-102, and VERVE-201 - target genes that have been extensively validated as targets… more